Tinnitus Treatment with Stem Cells
- Written by
- StemCell Longevita Editorial Team
- Medically reviewed by
- Prof. Dr. Erdal Karaöz TeamProfessor of Histology and Embryology · Medical Director, Center for Regenerative Medicine
- Last reviewed
- Next scheduled review
How we evaluate evidence · Conflict-of-interest disclosure · Editorial standards
Advanced mesenchymal regenerative medicine approach to reduce inner ear inflammation, restore auditory nerve function, and provide lasting tinnitus relief.
Can stem cell therapy help tinnitus?
Mesenchymal stem cell and exosome therapies are not approved treatments for tinnitus. Only a small number of preliminary studies have been reported, and none have demonstrated a consistent reduction in Tinnitus Handicap Inventory scores versus control. Established management — hearing-aid optimisation, cognitive behavioural therapy, tinnitus retraining therapy, and treatment of any underlying cause — remains the evidence-based approach.
Key facts
- Approval status
- Not approved for tinnitus
- Evidence
- Preliminary only; no consistent THI improvement
- Standard care
- Hearing-aid fitting, CBT, tinnitus retraining, cause-directed care
What we know
- MSC and exosome administration have short-term safety data in other indications that can inform tinnitus feasibility work.
What remains uncertain
- Whether MSC or exosome delivery to the inner-ear system produces any measurable audiological or perception change.
Medically reviewed questions
This summary is general medical information, not medical advice, and not a promise of benefit. Figures are quoted ranges, confirmed in writing after a medical review.
Medically reviewed by: Prof. Dr. Erdal Karaöz · Last updated: · Editorial and evidence policy
Evidence at a glance — Tinnitus
A plain summary of what the published research does and does not show for this condition. It is written to the same standard whether the evidence is strong or weak.
- Human studies available?
- Limited
- Randomised trials?
- None identified
- Main outcomes studied
- Tinnitus handicap inventory
- Loudness matching
- Audiometry
- Long-term evidence
- Very limited
- Regulatory approval for this indication
- United States (FDA): No FDA-approved mesenchymal stem cell product for this indication. The FDA has issued consumer warnings about unapproved stem cell products.
- European Union (EMA): No EMA-authorised mesenchymal stem cell medicine for this indication.
- United Kingdom (MHRA): No MHRA-authorised mesenchymal stem cell medicine for this indication.
- Türkiye (Ministry of Health): In Türkiye, cell therapies are delivered only inside Ministry of Health–licensed centres under the regenerative medicine / advanced therapy regulations, as clinical research or individual (exceptional) use — not as an approved routine treatment for this indication.
- Role at our centre
- Research context — considered only where standard care is exhausted or unsuitable, and never as a replacement for it
What kind of evidence exists
- Mechanism (laboratory): Documented
- Animal / preclinical: Documented
- Early human (phase 1/2, uncontrolled): Documented
- Controlled human (randomised or sham-controlled): Not established
- Regulatory approval: Not established
Sources
- Systematic reviews and meta-analyses — Tinnitus — PubMed
- Randomised controlled trials — Tinnitus — PubMed
- Registered MSC trials — Tinnitus — ClinicalTrials.gov
- FDA — Consumer alert on regenerative medicine therapies — U.S. Food and Drug Administration, 2024
- Advanced therapy medicinal products: overview — European Medicines Agency, 2025
- ISSCR Guidelines for Stem Cell Research and Clinical Translation — International Society for Stem Cell Research, 2021
- ISSCR Patient Handbook on Stem Cell Therapies — International Society for Stem Cell Research, 2020
Source links open filtered searches of PubMed and ClinicalTrials.gov plus regulator and professional-society pages, so you can read the current evidence yourself rather than a selected extract.
This summary is general information about the evidence base, not medical advice and not a promise of benefit. Whether any treatment is appropriate for you can only be decided after a medical review of your records.
What Is Tinnitus?
Tinnitus is the perception of ringing, buzzing, hissing, or other phantom sounds in the ears without an external source. It affects approximately 15-20% of the global population, with severity ranging from mild annoyance to debilitating interference with daily life, sleep, and concentration.
Tinnitus often results from damage to the delicate hair cells in the inner ear (cochlea), noise-induced hearing loss, age-related auditory degeneration, or inflammation of the auditory nerve pathways. Traditional treatments offer limited relief, focusing mainly on sound masking and cognitive behavioural therapy.
Regenerative medicine approach with mesenchymal stem cells offers a novel strategy by targeting the underlying cochlear damage, reducing neuroinflammation in the auditory pathways, and promoting the repair of damaged sensory cells — addressing the root causes rather than merely masking symptoms.
Benefits of Stem Cell Therapy for Tinnitus
MSC therapy targets the underlying auditory damage causing tinnitus, offering a regenerative approach to lasting relief.
Reduced Ringing Intensity
MSCs reduce neuroinflammation in the auditory cortex and cochlea, lowering the intensity and frequency of phantom sounds experienced by tinnitus patients.
Anti-Inflammatory Effects
MSCs deliver potent anti-inflammatory cytokines that reduce chronic inflammation in the inner ear structures, addressing one of the key mechanisms driving tinnitus.
Inner Ear Cell Repair
Stem cells secrete neurotrophic factors that support the survival and regeneration of damaged cochlear hair cells, the primary sensory receptors for hearing.
Enhanced Cochlear Blood Flow
Stem cells promote angiogenesis in the inner ear vasculature, improving blood supply to the cochlea and supporting nutrient delivery to damaged auditory cells.
Auditory Nerve Protection
MSCs provide neuroprotective support to the auditory nerve (cranial nerve VIII), helping restore normal signal transmission between the cochlea and brain.
Improved Quality of Life
As tinnitus symptoms decrease, many patients report significant improvements in sleep quality, concentration, and overall mental well-being.
Patient Experiences
Real outcomes from patients who chose regenerative medicine at StemCell Longevita Istanbul
"After 8 years of decline, I finally feel like I'm moving forward again. The team in Istanbul gave me something my neurologist at home couldn't — hope backed by real results."
"Within three months of treatment, our daughter started calling us by name. Her teachers noticed the difference before we even told them about the therapy."
Your Tinnitus Treatment Process
Our comprehensive approach begins with detailed audiological assessment and follows a personalized protocol designed for maximum auditory improvement.
Audiological Evaluation
Complete hearing assessment including audiometry, tympanometry, and tinnitus matching to characterize your specific condition.
Medical Consultation
Review of medical history, imaging results, and lab work with our specialists to design your personalized regenerative protocol.
Cell Preparation
Wharton's jelly MSCs are prepared in our GMP-certified laboratory with quality controls ensuring 97% cell viability.
Treatment Administration
IV infusion combined with targeted intratympanic delivery to maximize stem cell migration to the inner ear structures.
Follow-Up Monitoring
Regular audiological assessments at 1, 3, and 6 months to track hearing improvements and tinnitus reduction.
Frequently Asked Questions About Tinnitus Treatment
Find answers to the most common questions about stem cell therapy for tinnitus.
All Regenerative Medicine Applications
Explore our comprehensive range of regenerative medicine applications for various conditions. Click any option to learn more.
Related Articles
Explore our in-depth research articles and guides on related treatments and therapies.
Cerebral Palsy & Regenerative Medicine: New Hope for Children
Discover how mesenchymal stem cell approaches are supporting the care landscape for cerebral palsy, offering potential motor function improvement and quality of life for children and families worldwide.
Read ArticleRegenerative Medicine Application for Autism Spectrum Disorder
Explore the promising potential of regenerative medicine in addressing autism spectrum disorder symptoms, including potential improvements in communication, social interaction, and behavioral patterns.
Read ArticleStroke Progress: How Stem Cells Support Neurological Wellness
Exploring the potential of regenerative medicine in stroke rehabilitation, including mechanisms of action and reported improvements in motor and cognitive function.
Read ArticleRelated clinical questions
Where this page sits in the wider picture.